Health and Fitness Health and Fitness
Wed, June 20, 2012
[ Wed, Jun 20th 2012 ] - Market Wire
Immunovaccine's DPX-Survivac Featured in Presenta .. ical Immunology Societies Conference (FOCIS 2012)
[ Wed, Jun 20th 2012 ] - Market Wire
CytoSorbents Appoints Dr. Christian Steiner as VP .. ires Core Sales Force That Marks the Official Lau
[ Wed, Jun 20th 2012 ] - Market Wire
Echo Therapeutics Announces Patents for Symphony tCGM System and Prelude SkinPrep System
[ Wed, Jun 20th 2012 ] - Market Wire
CytoSorbents Announces Departure of CFO David Lamadrid
[ Wed, Jun 20th 2012 ] - Market Wire
University of North Texas Health Science Center A .. Investing in Semiconductor DNA Sequencing Technol
[ Wed, Jun 20th 2012 ] - Market Wire
Life Technologies to Collaborate with Boston Chil .. Optimized Lab Workflow based on the Ion Protona"
[ Wed, Jun 20th 2012 ] - Market Wire
AcelRx Pharmaceuticals Receives First U.S. Patent for Small-Volume Oral Transmucosal Dosage Forms
[ Wed, Jun 20th 2012 ] - Market Wire
Stellar Pharmaceuticals Acquires the Exclusive Rights to Collatamp G(R) in Canada
[ Wed, Jun 20th 2012 ] - Market Wire
InterMune Completes Divestiture of Actimmune (interferon gamma-1b)
[ Wed, Jun 20th 2012 ] - Market Wire
Implant Sciences Adds Former TSA Senior Executive Mo McGowan as Advisor
[ Wed, Jun 20th 2012 ] - Market Wire
Abbott Again Named One of the Best Workplaces in Europe
Tue, June 19, 2012
[ Tue, Jun 19th 2012 ] - Market Wire
BioSyent Pharma Secures Two Long-Term Hospital Su .. cts for Cathejell(TM) Jelly 2%-Shipments Commence
[ Tue, Jun 19th 2012 ] - Market Wire
AspenBio Pharma Announces Pricing of Public Offering of 6,100,000 Shares of Common Stock
[ Tue, Jun 19th 2012 ] - Market Wire
HealthSouth Corporation Signs Letter Of Intent To .. bilitation Unit Of CHRISTUS Santa Rosa Hospital -
[ Tue, Jun 19th 2012 ] - Market Wire
Cytokinetics Announces Proposed Public Offerings .. and Series B Convertible Preferred Stock and Warr
[ Tue, Jun 19th 2012 ] - Market Wire
Cytokinetics, Incorporated Receives NASDAQ Notice of Minimum Bid Price Non-Compliance
[ Tue, Jun 19th 2012 ] - Market Wire
Onyx Pharmaceuticals to Hold Conference Call on J .. Advisory Committee Recommendation for Kyprolisa"
[ Tue, Jun 19th 2012 ] - Market Wire
Patient Home Monitoring (PHM) Announces Monthly Progress Report for May 2012
[ Tue, Jun 19th 2012 ] - Market Wire
MyHealthDIRECT Strengthens Board of Directors, Wins HHS Innovation Award
[ Tue, Jun 19th 2012 ] - Market Wire
InternetArray Subsidiary Noobis Reports Increased Sales Margins and New Releases
[ Tue, Jun 19th 2012 ] - Market Wire
Enzon Announces Data From Phase I Study of PEG-SN .. and Other Solid Tumors Presented at 2012 Advance
[ Tue, Jun 19th 2012 ] - Market Wire
XTL Biopharmaceuticals to Acquire Kitov Pharmaceuticals
[ Tue, Jun 19th 2012 ] - Market Wire
Chembio Diagnostics Announces Positive Data From .. oint-of-Care Hepatitis C Test Published in the Jo
[ Tue, Jun 19th 2012 ] - Market Wire
Cytomedix Announces Participation at 2012 BIO International Convention
[ Tue, Jun 19th 2012 ] - Market Wire
Keryx Biopharmaceuticals Announces Live Webcast of Upcoming Analyst Day
[ Tue, Jun 19th 2012 ] - Market Wire
Ki Yong Choi Sends Letter to Cryo-Cell Stockholders
[ Tue, Jun 19th 2012 ] - Market Wire
Concerns of a Global Recession Haven't Held Back Booming Biotech Industry
[ Tue, Jun 19th 2012 ] - Market Wire
Biotech Industry Showing Investors Impressive Gains in 2012
[ Tue, Jun 19th 2012 ] - Market Wire
Equity Research on DaVita Inc. and HEALTHSOUTH Co .. -- Specialized Healthcare Companies Look to Grow
[ Tue, Jun 19th 2012 ] - Market Wire
ImmuCell Presents Strategic Overview at Annual Meeting of Stockholders

ImmuCell Presents Strategic Overview at Annual Meeting of Stockholders


Published on 2012-06-19 05:06:25 - Market Wire
  Print publication without navigation


June 19, 2012 08:00 ET

ImmuCell Presents Strategic Overview at Annual Meeting of Stockholders

PORTLAND, ME--(Marketwire - Jun 19, 2012) - ImmuCell Corporation (NASDAQ: [ ICCC ]) announced today that it presented a strategic overview of the Company's business at its Annual Meeting of Stockholders on June 14, 2012 and has today posted this information on the Investor Relations section of its website.

"This information was previously disclosed in Company filings with the SEC or is generally known publicly," commented Michael F. Brigham, President and CEO. "Because these 18 slides consolidate this information in one convenient place, we have also posted it on our website."

The results of the voting by stockholders at the Annual Meeting were filed with the SEC today on Form 8-K.

ImmuCell Corporation's (NASDAQ: [ ICCC ]) purpose is to create scientifically-proven and practical products that result in a measurable economic impact on animal health and productivity in the dairy and beef industries. Press releases and other information about the Company are available at our website, ([ http://www.immucell.com ]).


Contributing Sources